کاربرد درمان‌های ذهن‌آگاهانه در درمان نشانگان ناراحتی بدنی

نوع مقاله : مقاله مروری

نویسندگان

1 استادیار، گروه روان‌پزشکی، دانشکده‌ی پزشکی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران

2 استادیار، گروه روان‌پزشکی، دانشکده‌ی پزشکی، دانشگاه علوم پزشکی مشهد، مشهد، ایران

3 دانشیار، مرکز تحقیقات علوم رفتاری و گروه روان‌پزشکی، دانشکده‌ی پزشکی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران

چکیده

از دهه‌ی 1970، جریان یکپارچه شدن ذهن‌آگاهی با روان درمانی شروع شد. درمان‌های مبتنی بر ذهن‌آگاهی از جمله ذهن‌آگاهی مبتنی بر کاهش استرس، کاربرد وسیعی در درمان بیماران مبتلا به شرایط طبی مزمن دارند. این درمان‌ها تأکید می‌کنند که آگاهی نسبت به لحظه حال و پذیرش آن، از جنبه‌های مهم درمانی است. این اختلالات، از مشکلات بزرگ بهداشت عمومی هستند که کمتر درمان مؤثری برای آن‌ها روی ‌کار آمده ‌است. نشانگان جسمی عملکردی و جسمی‌سازی است که با اصطلاحی کلی‌تر، تحت عنوان نشانگان ناراحتی بدنی یکپارچه شده‌اند. در این اختلالات، پایه‌های جسمی مشخصی برای تبیین نشانه‌های بیماران یافت نمی‌شود. یکی از درمان‌های جدید در این حوزه، درمان‌های ذهن‌آگاهانه است که با آموزش آگاهی بدنی، ذهنی و ارتباط بین این دو، منجر به افزایش ماده‌ی خاکستری مغز در شکنج اینسولا، هیپوکامپ و کورتکس پیش‌پیشانی، افزایش فعالیت نواحی بالابرنده‌ی خلق در کورتکس پیشانی چپ، تقویت سیستم ایمنی و بهبود عملکرد روان‌شناختی مرتبط با پذیرش خود می‌گردد و علایم اختلال را کاهش و بهبود می‌دهد.

کلیدواژه‌ها

عنوان مقاله [English]

Application of Mindfulness-Based Therapies in Treatment of Bodily Distress Syndrome

نویسندگان [English]

  • Fatemeh Zargar 1
  • Negar Asgharipoor 2
  • Reza Bagherian-Sararoudi 3
1 Assistant Professor, Department of Clinical Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Assistant Professor, Department of Clinical Psychiatry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3 Associate Professor, Behavioral Sciences Research Center AND Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
چکیده [English]

Mindfulness and psychotherapy integration movement has begun since the 1970s. Mindfulness-based therapies such as mindfulness-based stress reduction (MBSR), are widely used in the treatment of patients with chronic medical conditions. These therapies focus on the present moment awareness and acceptance as an important aspect of treatment. One of the major public health problems is functional somatic syndromes and somatization. There are a few effective treatments for them. These two problems have been united with the term as bodily distress syndrome (BDS); the clear somatic basis has not been found. Of the new therapies in the treatment of bodily distress syndrome are mindfulness-based therapies. These therapies, via mind and body awareness training and connection between mind and body, increase brain gray matter in the insula, hippocampus and prefrontal cortex. They increase activity of the left frontal areas elevating mood and boost the immune system, too. These therapies improve mental performance related to its acceptance and decrease the symptoms of bodily distress syndrome.

کلیدواژه‌ها [English]

  • Bodily distress syndrome
  • Mindfulness
  • Mindfulness-based stress reduction

مراجع

  1. Zargar F, Mohammadi A, Omidi A, Bagherian-Sararoudi R. The third wave of behavior therapy with emphasis on acceptance-based behavior therapy. J Res Behav Sci 2013; 10(5): 383-90. [In Persian].
  2. Zargar F, Farid AA, Atef-Vahid MK, Afshar H, Omidi A. Comparing the effectiveness of acceptance-based behavior therapy and applied relaxation on acceptance of internal experiences, engagement in valued actions and quality of life in generalized anxiety disorder. J Res Med Sci 2013; 18(2): 118-22.
  3. Hayes SC, Strosahl K, Wilson KG, Bissett RT, Pistorello J, Toarmino D. Measuring experiential avoidance: A preliminary test of a working model. The Psychological Record 2004; 54(4): 553–78.
  4. Hayes SC, Strosahl K, Wilson KG. Acceptance and Commitment Therapy. New York, NY: The Guilford Press; 1999.
  5. Roemer L, Orsillo SM. Mindfulness and acceptance-based behavioral therapies in practice. New York, NY: The Guilford Press; 2010.
  6. Roemer L, Salters K, Raffa S, Orsillo SM. Fear and avoidance of internal experiences in GAD: Preliminary tests of a conceptual model. Cognitive Therapy and Research 2005: 29(1): 71-88.
  7. Hayes SC. Content, context, and the types of psychological acceptance. In: Hayes SC, Jacobsen NS, Follette VM, Dougher MJ, editors Acceptance and chance: Content and context in psychotherapy. Reno, NV: Context Press; 1994. p. 13-32.
  8. Roemer L, Orsillo SM. Mindfulness: A promising intervention strategy in need of further study. Clinical Psychology: Science and Practice 2003; 10(2): 172-8.
  9. Hayes SC, Duckworth MP. Acceptance and commitment therapy and traditional cognitive behavior therapy approaches to pain. Cognitive and Behavioral Practice 2006; 13(3): 185-7.
  10. Zargar F. Comparing the effectiveness of acceptance-based behavior therapy and applied relaxation on women with generalized anxiety disorder [PhD Thesis]. Tehran, Iran: Tehran Psychiatric Institute; 2011. [In Persian].
  11. Baer R A. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clinical Psychology: Science and Practice 2003; 10(2): 125-43.
  12. Hayes SC, Wilson KG. Mindfulness: Method and Process. Clinical Psychology: Science and Practice 2003; 10(2): 161-5.
  13. Cardaciotto LA. Assessing mindfulness: the development of a bi-dimensional measure of awareness and acceptance [PhD Thesis]. Philadelphia, PA; Drexel University; 2005.
  14. Bargh JA, Ferguson MJ. Beyond behaviorism: on the automaticity of higher mental processes. Psychol Bull 2000; 126(6): 925-45.
  15. Kirsch I, Lynn SJ. Automaticity in clinical psychology. Am Psychol 1999; 54(7): 504-15.
  16. Bishop SR. What do we really know about mindfulness-based stress reduction? Psychosom Med 2002; 64(1): 71-83.
  17. Breslin FC, Zack M, McMain S. An information-processing analysis of mindfulness: implications for relapse prevention in the treatment of substance abuse. Clinical Psychology: Science and Practice 2002; 9(3): 275-99.
  18. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: One or many? Lancet 1999; 354(9182): 936-9.
  19. Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol 2011; 7(9): 518-27.
  20. Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 2005; 30(10): 996-1002.
  21. Rosenkranz MA. Substance P at the nexus of mind and body in chronic inflammation and affective disorders. Psychol Bull 2007; 133(6): 1007-37.
  22. Clauw DJ. Potential mechanisms in chemical intolerance and related conditions. Ann N Y Acad Sci 2001; 933: 235-53.
  23. Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988; 32(1): 21-6.
  24. Kwiatek R, Barnden L, Tedman R, Jarrett R, Chew J, Rowe C, et al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000; 43(12): 2823-33.
  25. MacHale SM, Lawrie SM, Cavanagh JT, Glabus MF, Murray CL, Goodwin GM, et al. Cerebral perfusion in chronic fatigue syndrome and depression. Br J Psychiatry 2000; 176: 550-6.
  26. Vuilleumier P, Chicherio C, Assal F, Schwartz S, Slosman D, Landis T. Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain 2001; 124(Pt 6): 1077-90.
  27. Tirelli U, Chierichetti F, Tavio M, Simonelli C, Bianchin G, Zanco P, et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998; 105(3A): 54S-58S.
  28. Hakala M, Karlsson H, Ruotsalainen U, Koponen S, Bergman J, Stenman H, et al. Severe somatization in women is associated with altered cerebral glucose metabolism. Psychol Med 2002; 32(8): 1379-85.
  29. Garcia-Campayo J, Sanz-Carrillo C, Baringo T, Ceballos C. SPECT scan in somatization disorder patients: an exploratory study of eleven cases. Aust N Z J Psychiatry 2001; 35(3): 359-63.
  30. Wik G, Fischer H, Bragee B, Kristianson M, Fredrikson M. Retrosplenial cortical activation in the fibromyalgia syndrome. Neuroreport 2003; 14(4): 619-21.
  31. Kuzminskyte R, Kupers R, Videbech P, Gjedde A, Fink P. Increased sensitivity to supra-threshold painful stimuli in patients with multiple functional somatic symptoms (MFS). Brain Res Bull 2010; 82(1-2): 135-40.
  32. Rief W, Broadbent E. Explaining medically unexplained symptoms-models and mechanisms. Clin Psychol Rev 2007; 27(7): 821-41.
  33. van West D, Maes M. Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression. Neuro Endocrinol Lett 1999; 20(1-2): 11-7.
  34. Schins A, Tulner D, Lousberg R, Kenis G, Delanghe J, Crijns HJ, et al. Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatr Res 2005; 39(2): 137-44.
  35. Davidson RJ. Affective neuroscience and psychophysiology: toward a synthesis. Psychophysiology 2003; 40(5): 655-65.
  36. Ott U, Holzel BK, Vaitl D. Brain structure and meditation. How spiritual practice shapes the brain. In: Walach H, Schmidt S, Jonas WB, editors. Neuroscience, consciousness and spirituality. Berlin, Germany: Springer; 2011.
  37. Pagnoni G, Cekic M. Age effects on gray matter volume and attentional performance in Zen meditation. Neurobiol Aging 2007; 28(10): 1623-7.
  38. Pagnoni G, Cekic M, Guo Y. "Thinking about not-thinking": neural correlates of conceptual processing during Zen meditation. PLoS One 2008; 3(9): e3083.
  39. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain and illness. New York, NY: Delacorte; 1990.
  40. Goleman D. Destructive emotions. How can we overcome them? A scientific dialogue with the Dalai Lama. New York, NY: Bantam; 2003.
  41. Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med 2003; 65(4): 564-70.
  42. Holzel BK, Carmody J, Vangel M, Congleton C, Yerramsetti SM, Gard T, et al. Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Res 2011; 191(1): 36-43.
  43. Holzel BK, Ott U, Gard T, Hempel H, Weygandt M, Morgen K, et al. Investigation of mindfulness meditation practitioners with voxel-based morphometry. Soc Cogn Affect Neurosci 2008; 3(1): 55-61.
  44. Carr L, Iacoboni M, Dubeau MC, Mazziotta JC, Lenzi GL. Neural mechanisms of empathy in humans: a relay from neural systems for imitation to limbic areas. Proc Natl Acad Sci USA 2003; 100(9): 5497-502.
  45. Siegel DJ. The mindful brain: reflection and attunement in the cultivation of well-being. New York, NY: W. W. Norton and Company; 2007.
  46. Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science 2000; 288(5472): 1769-72.
  47. Lapate RC, Lee H, Salomons TV, van Reekum CM, Greischar LL, Davidson RJ. Amygdalar function reflects common individual differences in emotion and pain regulation success. J Cogn Neurosci 2012; 24(1): 148-58.
  48. Davidson RJ. Affective style, psychopathology, and resilience: brain mechanisms and plasticity. Am Psychol 2000; 55(11): 1196-214.
  49. Davidson RJ. Well-being and affective style: neural substrates and biobehavioural correlates. Philos Trans R Soc Lond B Biol Sci 2004; 359(1449): 1395-411.
  50. Ricard M. Happiness: A guide to developing life's most important skill. New York, NY: Little, Brown and Company; 2007.
  51. Luders E, Toga AW, Lepore N, Gaser C. The underlying anatomical correlates of long-term meditation: larger hippocampal and frontal volumes of gray matter. Neuroimage 2009; 45(3): 672-8.
  52. Brown M. The Presence process a healing journey into present moment awareness. New York, NY: Beaufort Books; 2005.
  53. Eisenberg DM, Harris ES, Littlefield BA, Cao S, Craycroft JA, Scholten R, et al. Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation--rationale, methods and preliminary results from a Sino-American collaboration. Fitoterapia 2011; 82(1): 17-33.
  54. Habibi M, Bagherian-Sararoudi R. Psychological consequences of chronic pain: A focus on suicidal ideation and psychological interventions. J Res Behave Sci 2013; 11(4). [In Persian].
  55. Kheirabadi GR, Toghani F, Kousha M, Hashemi M, Maracy MR, Sharifi MR, et al. Is there any association of anxiety-depressive symptoms with vascular endothelial function or systemic inflammation? J Res Med Sci 2013; 18(11): 979-83.
مجله دانشکده پزشکی اصفهان
دوره 33، شماره 348 - شماره پیاپی 348
مهر و آبان 1394
صفحه 1430-1439

فایل ها

سابقه مقاله

  • تاریخ دریافت: 15 بهمن 1392
  • تاریخ بازنگری: 11 آبان 1403
  • تاریخ پذیرش: 17 فروردین 1401

هم رسانی

ارجاع به این مقاله

آمار